Christophe Zemmour

Paoli-Calmettes Institute

France

SCHOLARLY PAPERS

1

DOWNLOADS

29

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Parp Inhibitors as Maintenance Therapy in Ovarian Cancer after Platinum-Sensitive Recurrence: Real-World Experience from the Unicancer Network

Number of pages: 25 Posted: 20 Dec 2023 Last Revised: 29 Mar 2024
University Hospital of Limoges, Paoli-Calmettes Institute, University of Paris, University of Claude Bernard Lyon 1 - Medical Oncology Department, Institut Claudius Regaud, Université Paris XI Sud - Gustave Roussy Cancer Campus, Institut de Cancérologie de l’Ouest Pays de Loire, Centre Georges-François Leclerc - Department of Medical Oncology, University of Bordeaux - Department of Medical Oncology, Université de Clermont Auvergne, University of Montpellier - Institute for Cancer Research in Montpellier, University of Lorraine, Centre Henri Becquerel, Institut Curie - Department of Medical Oncology, Institut de Cancérologie de Strasbourg Europe, UNICANCER, Limoges University Hospital and Aix-Marseille-Univ
Downloads 29 (1,049,863)

Abstract:

Loading...

Real word data. PARP inhibitor. Platinum-sensitive. Maintenance therapy. Recurrent ovarian cancer